Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients.
<h4>Background</h4>The pancreatitis-associated protein (PAP) is increased in the serum of active inflammatory bowel disease (IBD) patients and its levels seem to be correlated with disease activity. Our aim was to evaluate the usefulness of serum and fecal PAP measurements to predict rel...
Main Authors: | Tiago Nunes, Maria Josefina Etchevers, Maria Jose Sandi, Susana Pinó Donnay, Teddy Grandjean, Maria Pellisé, Julián Panés, Elena Ricart, Juan Lucio Iovanna, Jean-Charles Dagorn, Mathias Chamaillard, Miquel Sans |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24416322/?tool=EBI |
Similar Items
-
Serrated polyposis syndrome associated with long-standing inflammatory bowel disease
by: Jesús Castro, et al. -
Biosimilar therapy for inflammatory bowel disease
by: Cristina Avendaño-Solá, et al. -
The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases
by: Bianca J. Galgut, et al.
Published: (2018-01-01) -
Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis.
by: Lluís Revilla, et al.
Published: (2021-01-01) -
Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease
by: Fang Liu, et al.
Published: (2020-12-01)